|
Delayed
OTC Markets
22:06:37 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 21/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | - | - | - | - | - | 1 | |
| +0.34% | -3.03% | -11.69% | +16.15% | +57.65% | +37.45% | +61.06% | +6.44% | - | 64.14B | |
| +0.98% | +2.68% | -5.19% | +3.71% | +12.22% | +12.25% | +83.90% | +210.70% | +5,645.71% | 55.53B | |
| +1.75% | +2.01% | +9.73% | +11.48% | +19.15% | +13.30% | +105.71% | -14.63% | +243.04% | 53.03B | |
| -2.00% | -1.79% | +1.61% | +10.41% | +21.26% | +25.48% | +54.28% | +4.56% | +281.00% | 45.99B | |
| -1.06% | -3.41% | +1.08% | +12.84% | +21.53% | +17.27% | +97.86% | +3.21% | +1,010.77% | 42.45B | |
| -0.37% | +0.31% | -7.93% | +4.06% | +136.37% | +224.49% | +925.99% | +539.72% | - | 40.45B | |
| -0.26% | -4.20% | +6.17% | +6.71% | +9.81% | +10.86% | +45.18% | +6.84% | +157.79% | 32.25B | |
| -2.07% | +42.73% | +63.49% | +102.89% | +86.88% | +103.77% | +90.26% | +31.35% | +238.82% | 34.47B | |
| -2.72% | -8.79% | -15.62% | +16.80% | +43.32% | +22.58% | -5.63% | -60.89% | - | 24.23B | |
| -0.08% | -2.03% | -10.88% | -5.49% | -7.72% | -15.00% | -5.79% | -68.48% | - | 22.1B | |
| +12.75% | +14.49% | -5.88% | +5.54% | -37.47% | -34.81% | +357.27% | +260.96% | +738.44% | 21.18B | |
| -2.22% | +3.66% | +8.97% | +15.90% | +20.70% | +15.97% | +180.36% | +199.23% | +2,235.99% | 19.38B | |
| +0.34% | +10.45% | +26.76% | +59.77% | +88.06% | +108.24% | +128.03% | -16.39% | +394.40% | 17.85B | |
| +0.97% | +4.59% | +14.28% | +26.86% | +39.55% | +43.70% | +86.35% | -14.58% | +110.39% | 16.69B | |
| -0.75% | +0.56% | +11.98% | +18.70% | +49.84% | +66.56% | +224.48% | +205.32% | +520.16% | 16.42B | |
| +0.74% | +3.45% | +10.22% | -0.27% | - | - | - | - | - | 16.39B | |
| +3.33% | +5.53% | +7.36% | +11.21% | +192.66% | +175.10% | +360.46% | +1,478.53% | +825.12% | 15.33B | |
| -0.42% | +15.62% | +25.86% | +20.33% | +17.66% | +29.20% | -9.97% | -25.24% | +167.07% | 16.04B | |
| +0.97% | -7.48% | -3.82% | -13.90% | +11.63% | +3.79% | +468.94% | - | - | 13.21B | |
| Average | +0.49% | +3.67% | +6.66% | +17.04% | +43.51% | +47.79% | +180.49% | +161.57% | +966.82% | 28.36B | |
| Weighted average by Cap. | +0.28% | +3.36% | +4.68% | +17.01% | +41.83% | +46.20% | +168.18% | +123.35% | +1,260.30% |
- Stock Market
- Stocks
- SEELQ Stock
- Sector Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
